Benefits and Risks of Prolonged Duration Dual Antiplatelet Therapy (Clopidogrel and Aspirin) After Percutaneous Coronary Intervention in High-Risk Patients With Diabetes Mellitus.

Wang, Hao-Yu; Cai, Zhong-Xing; Yin, Dong; Yang, Yue-Jin; Song, Wei-Hua; Dou, Ke-Fei

Wang, Hao-Yu; Cai, Zhong-Xing; Yin, Dong; Yang, Yue-Jin; Song, Wei-Hua; Dou, Ke-Fei.

Afiliación

Wang HY; Department of Cardiology, Coronary Heart Disease Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; State Key Laboratory of Cardiovascular Disease, Beijing, China; National Clinical Research Cente
Cai ZX; Department of Cardiology, Coronary Heart Disease Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; State Key Laboratory of Cardiovascular Disease, Beijing, China; National Clinical Research Cente
Yin D; Department of Cardiology, Coronary Heart Disease Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Yang YJ; Department of Cardiology, Coronary Heart Disease Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; State Key Laboratory of Cardiovascular Disease, Beijing, China; National Clinical Research Cente
Song WH; Department of Cardiology, Coronary Heart Disease Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; State Key Laboratory of Cardiovascular Disease, Beijing, China; National Clinical Research Cente
Dou KF; Department of Cardiology, Coronary Heart Disease Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; State Key Laboratory of Cardiovascular Disease, Beijing, China; National Clinical Research Cente

Am J Cardiol ; 142: 14-24, 2021 03 01.

Article en En | MEDLINE | ID: mdl-33285091

Asunto(s)

Enfermedad de la Arteria Coronaria/cirugía; Complicaciones de la Diabetes; Diabetes Mellitus; Duración de la Terapia; Mortalidad; Infarto del Miocardio/epidemiología; Inhibidores de Agregación Plaquetaria/uso terapéutico; Accidente Cerebrovascular/epidemiología; Anciano; Aspirina/uso terapéutico; Clopidogrel/uso terapéutico; Enfermedad de la Arteria Coronaria/complicaciones; Terapia Antiplaquetaria Doble/métodos; Femenino; Hemorragia/inducido químicamente; Hemorragia/epidemiología; Humanos; Masculino; Persona de Mediana Edad; Análisis Multivariante; Intervención Coronaria Percutánea; Cuidados Posoperatorios; Modelos de Riesgos Proporcionales; Sistema de Registros; Medición de Riesgo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Inhibidores de Agregación Plaquetaria / Mortalidad / Accidente Cerebrovascular / Complicaciones de la Diabetes / Diabetes Mellitus / Duración de la Terapia / Infarto del Miocardio Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Cardiol Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google